Related Experiment Videos
JAKs, STATs and Src kinases in hematopoiesis
Sushil G Rane1, E Premkumar Reddy
1Laboratory of Cell Regulation & Carcinogenesis, NCI, NIH, Bldg. 41, C629, 41 Library Drive, Bethesda, Maryland, MD 20892, USA.
Oncogene
|May 29, 2002
Summary
Cytokines and their receptors initiate complex signaling pathways, involving Janus kinases (JAKs) and signal transducers and activators of transcription (STATs). These pathways are crucial for normal blood cell development and implicated in blood cancers.
Area of Science:
- Molecular Biology
- Cell Signaling
- Hematology
Background:
- Hematopoiesis involves intricate signal transduction cascades mediated by cytokines and receptors.
- Aberrations in these pathways cause diseases like leukemia and other myeloproliferative/lymphoproliferative disorders.
Purpose of the Study:
- To elucidate the key signaling molecules and pathways governing hematopoiesis.
- To understand the roles of JAKs, Src kinases, and STATs in cytokine-mediated cellular processes.
Main Methods:
- Focus on downstream signal transduction events following cytokine/growth factor stimulation.
- Review of emerging concepts in cell signaling research.
Main Results:
- Signal transducers and activators of transcription (STATs) orchestrate downstream events.
- Janus kinases (JAKs) and Src family kinases are critical for diverse signaling pathways.
- JAKs are essential for cytokine receptor phosphorylation, creating docking sites for STATs and other signaling proteins.
Conclusions:
- STAT protein activation is mediated by JAK and Src family kinases.
- Integration of signaling cues from JAKs, Src kinases, and STATs drives cell proliferation, survival, and differentiation.
- Understanding these pathways is key to addressing hematological diseases.